Published : Aug-2017
No. of Pages : 84
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Gaucher Disease Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profile Snapshots 33
Appendix 82
Abbreviations 82
Definitions 82
Research Methodology 83
Secondary Research 83
About GlobalData 84
Contact Us 84
Source 84
List of Tables
Gaucher Disease Therapeutics, Global, Clinical Trials by Region, 2017* 7
Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 16
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 19
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Gaucher Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
List of Figures
Gaucher Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 16
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 19
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Gaucher Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
GlobalData Methodology 83
